Riskpilot← Back to searchSign inGet full accessAmbria Dermatology AB
ABActiveOrg 5566178751Snickaregatan 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 20010 employees
Revenue 2024
SEK 45K
-13% vs 2023
EBITDA margin
-511.1%
-389% vs 2023
Equity ratio
98.3%
Financial strength
Net profit 2024
SEK 36K
-95% vs 2023
| Revenue | SEK 45K | -13% |
| EBITDA | SEK -230K | -389% |
| Net profit | SEK 36K | -95% |
| Total assets | SEK 3,3M | +2% |
| Equity | SEK 3,2M | +1% |
| Employees | 0 | — |
Legal name
Ambria Dermatology AB
Org number
5566178751
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
6 november 2001
Share capital
SEK 211 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva forskning, utveckling, utbildning, marknadsföring och försäljning av farmaceutiska och kosmetiska produkter samt därmed förenlig verksamhet.
Address
Snickaregatan 10
Phone
+4636396550
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 192 | 57 | 39 | 52 | 45 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −271 | −475 | −258 | −47 | −230 |
| Depreciation & amort. | −551 | −544 | −526 | −526 | −525 |
| EBIT | −822 | −1 019 | −784 | −573 | −755 |
| Net financials | — | — | — | — | — |
| Profit before tax | −822 | 822 | −784 | 784 | 45 |
| Tax | −0 | −0 | −0 | −0 | −9 |
| Net profit | −822 | 822 | −784 | 784 | 36 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 507 | 3 228 | 2 451 | 3 207 | 3 286 |
| Equity | 2 373 | 3 195 | 2 412 | 3 195 | 3 231 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 134 | 33 | 39 | 12 | 55 |
| Total debt | 134 | 33 | 39 | 12 | 55 |
EBITDA margin
-511.1%
This company
15.8%
Market median
-3335% vs market
20202024
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
1.1%
This company
18.4%
Market median
-94% vs market
20202024
Net profit margin
80.0%
This company
8.1%
Market median
+888% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SC Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
BM Chief Auditor | Chief Auditor | 2020 – 2020 |
BC Chief Auditor | Chief Auditor | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Former (6) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2022 – 2025 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Humble Group AB
Ambria Dermatology AB Board members of Ambria Dermatology AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Magnus Lagerberg | Chief Auditor | 0 companies |
| Sandra Clara Ellen Hvitman | Chief Auditor | 0 companies |
| Bengt Claes Joakim Falck | Chief Auditor | 0 companies |
| Kjell Lundgren | Deputy Board Member | 0 companies |
| Emil Mikael Svahn | Board of Directors | 0 companies |
| Noel Christofer Peter Abdayem | Board of Directors | 0 companies |
| Simon Gustav Seved Petrén | Chairman | 0 companies |
| Marcus Erik Johan Stenkil | Chairman | 0 companies |
| Johan Christer Lennartsson | Board of Directors | 0 companies |
| Ulrika Ann-Britt Albers | Chairman | 0 companies |
| Bengt Peter Carlsson | Board of Directors | 0 companies |
| Jan Peter Hencz | Chairman | 0 companies |